As an upstream supplier of raw materials and technical solutions in the fields of healthcare and life science, the company is committed to providing timely, stable and high-quality products and services to downstream customers, and helping global biomedical companies and research institutes innovate and upgrade technology and products. The company's main business is R&D, production and sales of target and factor proteins, recombinant antibodies, enzymes and reagents, and providing full-process application solutions in the fields of biopharmaceuticals, in vitro diagnostics, mRNA vaccine drugs, and basic life science research. The company's main products are diagnostic antigens, target proteins, cytokines, diagnostic antibodies, other antibodies, mRNA raw enzymes and reagents, molecular diagnostic enzymes and reagents, enzymes and reagents for life science research, enzymes and reagents for other pharmaceuticals, customized technical services and technology package transfers. Corporate honors: “Asia Pacific CGT Industry Star - 2023 Best Raw Material Provider”, “2023 Future Medical Top 100 · Innovative Medical Business and Supply Chain Service Top 100”, “2023 Synthetic Biology Industry Value Gold List”, “2023 China's Top 100 Life Science Service Enterprise Brands” and many other honorary titles.